Bridges Investment Counsel Inc. Has $364,000 Stake in Becton, Dickinson and Company (BDX)

Bridges Investment Counsel Inc. reduced its position in shares of Becton, Dickinson and Company (NYSE:BDX) by 29.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,857 shares of the medical instruments supplier’s stock after selling 764 shares during the period. Bridges Investment Counsel Inc.’s holdings in Becton, Dickinson and were worth $364,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of BDX. Almanack Investment Partners LLC. purchased a new stake in Becton, Dickinson and in the first quarter worth about $105,000. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its holdings in Becton, Dickinson and by 55.8% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 670 shares of the medical instruments supplier’s stock worth $131,000 after buying an additional 240 shares during the period. Parkside Financial Bank & Trust lifted its holdings in Becton, Dickinson and by 8.1% in the second quarter. Parkside Financial Bank & Trust now owns 684 shares of the medical instruments supplier’s stock worth $133,000 after buying an additional 51 shares during the period. Harfst & Associates Inc. lifted its holdings in Becton, Dickinson and by 46.4% in the second quarter. Harfst & Associates Inc. now owns 697 shares of the medical instruments supplier’s stock worth $135,000 after buying an additional 221 shares during the period. Finally, Financial Architects Inc lifted its holdings in Becton, Dickinson and by 8.0% in the second quarter. Financial Architects Inc now owns 731 shares of the medical instruments supplier’s stock worth $142,000 after buying an additional 54 shares during the period. Institutional investors own 86.70% of the company’s stock.

Several brokerages have commented on BDX. BidaskClub upgraded shares of Becton, Dickinson and from a “hold” rating to a “buy” rating in a report on Monday, August 14th. Royal Bank Of Canada restated a “hold” rating and issued a $210.00 price objective on shares of Becton, Dickinson and in a report on Wednesday, October 25th. Zacks Investment Research upgraded shares of Becton, Dickinson and from a “sell” rating to a “hold” rating in a report on Friday, October 20th. Cowen and Company restated an “outperform” rating and issued a $230.00 price objective (up from $200.00) on shares of Becton, Dickinson and in a report on Monday, July 10th. Finally, Barclays PLC restated an “equal weight” rating and issued a $210.00 price objective (up from $205.00) on shares of Becton, Dickinson and in a report on Thursday, August 10th. Five research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $205.14.

Shares of Becton, Dickinson and Company (NYSE:BDX) opened at 208.65 on Tuesday. The company’s 50 day moving average is $199.98 and its 200 day moving average is $195.13. The company has a market cap of $47.48 billion, a P/E ratio of 60.43 and a beta of 1.05. Becton, Dickinson and Company has a 12 month low of $161.29 and a 12 month high of $214.72.

Becton, Dickinson and (NYSE:BDX) last posted its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, beating the Zacks’ consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The company had revenue of $3.04 billion during the quarter, compared to analysts’ expectations of $3.06 billion. During the same quarter in the prior year, the company posted $2.35 earnings per share. Becton, Dickinson and’s revenue for the quarter was down 5.1% compared to the same quarter last year. On average, equities research analysts predict that Becton, Dickinson and Company will post $9.46 EPS for the current fiscal year.

In related news, insider Nabil Shabshab sold 6,149 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $201.76, for a total transaction of $1,240,622.24. Following the completion of the sale, the insider now owns 15,648 shares of the company’s stock, valued at $3,157,140.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Gary M. Cohen sold 15,512 shares of the stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $203.77, for a total transaction of $3,160,880.24. Following the sale, the insider now directly owns 95,781 shares of the company’s stock, valued at approximately $19,517,294.37. The disclosure for this sale can be found here. Insiders have sold 75,904 shares of company stock valued at $15,242,688 in the last three months. 1.40% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another publication, it was stolen and reposted in violation of United States & international copyright and trademark laws. The correct version of this piece of content can be read at https://www.com-unik.info/2017/10/31/bridges-investment-counsel-inc-has-364000-stake-in-becton-dickinson-and-company-bdx.html.

Becton, Dickinson and Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

What are top analysts saying about Becton Dickinson and Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Becton Dickinson and Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit